GSK plc

Common Name

GSK

Country

United Kingdom

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

68,629

Ticker

GSK

Exchange

LONDON STOCK EXCHANGE

Website

www.gsk.com

Description

GSK plc is a leading global healthcare company that researches, develops, and manufactures innovative pharmaceutical and consumer healthcare products. This company primarily focuses on creating vaccin... Show more

Financial Statements of GSK

Below are the financial statements of GSK, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of GBP	2024	2023
Non-current assets	—	—
Property, plant and equipment	9,227^a	9,020^a
Right of use assets	846^a	937^a
Goodwill	6,982^a	6,811^a
Other intangible assets	15,515^a	14,768^a
Investments in associates and joint ventures	96^a	55^a
Other investments	1,100^a	1,137^a
Deferred tax assets	6,757^a	6,049^a
Derivative financial instruments	1^a	0^a
Other non-current assets	1,942^a	1,584^a
Total non-current assets	42,466^a	40,361^a
Current assets	—	—
Inventories	5,669^a	5,498^a
Current tax recoverable	489^a	373^a
Trade and other receivables	6,836^a	7,385^a
Derivative financial instruments	109^a	130^a
Current equity investments	0^a	2,204^a
Liquid investments	21^a	42^a
Cash and cash equivalents	3,870^a	2,936^a
Assets held for sale	3^a	76^a
Total current assets	16,997^a	18,644^a
Total assets	59,463^a	59,005^a
Current liabilities	—	—
Short-term borrowings	-2,349^a	-2,813^a
Contingent consideration liabilities	-1,172^a	-1,053^a
Trade and other payables	-15,335^a	-15,844^a
Derivative financial instruments	-192^a	-114^a
Current tax payable	-703^a	-500^a
Short-term provisions	-1,946^a	-744^a
Total current liabilities	-21,697^a	-21,068^a
Non-current liabilities	—	—
Long-term borrowings	-14,637^a	-15,205^a
Corporation tax payable	0^a	-75^a
Deferred tax liabilities	-382^a	-311^a
Pensions and other post-employment benefits	-1,864^a	-2,340^a
Other provisions	-589^a	-495^a
Contingent consideration liabilities	-6,108^a	-5,609^a
Other non-current liabilities	-1,100^a	-1,107^a
Total non-current liabilities	-24,680^a	-25,142^a
Total liabilities	-46,377^a	-46,210^a
Net assets	13,086^a	12,795^a
Equity	—	—
Share capital	1,348^a	1,348^a
Share premium account	3,473^a	3,451^a
Retained earnings	7,796^a	7,239^a
Other reserves	1,054^a	1,309^a
Shareholders’ equity	13,671^a	13,347^a
Non-controlling interests	-585^a	-552^a
Total equity	13,086^a	12,795^a

Verified Sources Behind GSK’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.

a. GSK's Annual Report 2024

Trace every data point back to GSK’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

GSK plc

Financial Statements of GSK

Verified Sources Behind GSK’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

AstraZeneca PLC

Verona Pharma PLC

LivaNova PLC

Smith & Nephew PLC

Haleon PLC

ConvaTec Group PLC